investordatabase.org

Ampersand Capital Partners

ampersandcapital.com Direct investor

Ampersand Capital Partners is a private equity firm focused on healthcare and life sciences, making minority and majority equity investments in growth-oriented companies. It provides strategic and operational support to its portfolio companies.

Ampersand Capital Partners is a private equity firm headquartered in Boston, United States, founded in 1988. It invests directly in companies, from growth to buyout, in laboratory Products, laboratory Services, contract Manufacturing and pharma Services. Its stated cheque size is $10 to $200 million of equity. $3 billion in assets under management under management and 80 portfolio companies, as it reports.

“With more than 30 years dedicated to the life sciences sector, Ampersand Capital Partners has established a track record as the industry leader at the forefront of transformative investments serving science.”

— Ampersand Capital Partners, own website
Layer
Direct investor
Type
Private equity
Stage
Growth – Buyout
Headquarters
Boston, United States
Invests in
North America, Europe, APAC
Sectors
Laboratory Products, Laboratory Services, Contract Manufacturing, Pharma Services, Specialty Products
Cheque size
$10 to $200 million of equity
Founded
1988
Assets under management
$3 billion in assets under management
Portfolio
80 companies

Most shared portfolio companies with

Derived from portfolio pages both investors publish themselves: each pair below lists at least one company in common. 62 investors with a shared portfolio company. A shared company is not proof they invested together in the same round.

and 52 more — the graph.

Where this comes from

Every fact above was read from a page Ampersand Capital Partners publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.

Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.

Record 4572 · added 2026-09-03 · link last verified 2026-10-21 · confidence high

Similar investors

Listed under